PETS
PetMed Express, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$1.80
−2.70%Margins
Gross margin
23.7%
EBITDA margin
-12.9%
EBIT margin
-18.2%
Net margin
-17.3%
FCF margin
-16.4%
-127.4%
Return on equity
-45.9%
Return on assets
-131.5%
Return on invested capital
2.33x
Asset turnover
-$23.8M
Cash from operations
$0.60
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026